Piotr Boros

1.1k total citations
41 papers, 771 citations indexed

About

Piotr Boros is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Piotr Boros has authored 41 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in Piotr Boros's work include Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Respiratory Support and Mechanisms (11 papers). Piotr Boros is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Respiratory Support and Mechanisms (11 papers). Piotr Boros collaborates with scholars based in Poland, United States and Iran. Piotr Boros's co-authors include Philip H. Quanjer, Jeffrey J. Pretto, Danny J. Brazzale, Daniel J. Weiner, S Wesółowski, Magdalena Martusewicz-Boros, Kazimierz Roszkowski‐Śliż, Elżbieta Wiatr, Wojciech Lubiński and Paul Enright and has published in prestigious journals such as PLoS Medicine, Ecological Economics and European Respiratory Journal.

In The Last Decade

Piotr Boros

37 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piotr Boros Poland 13 660 399 57 55 47 41 771
An Lehouck Belgium 9 757 1.1× 472 1.2× 74 1.3× 46 0.8× 20 0.4× 17 1.1k
Hugues Morel France 10 566 0.9× 229 0.6× 45 0.8× 80 1.5× 60 1.3× 36 758
M. C. Zoia Italy 15 542 0.8× 356 0.9× 48 0.8× 48 0.9× 72 1.5× 21 752
Levent Cem Mutlu Türkiye 12 501 0.8× 277 0.7× 36 0.6× 72 1.3× 42 0.9× 34 736
A. Cavaillès France 10 574 0.9× 174 0.4× 38 0.7× 78 1.4× 64 1.4× 16 689
Elizabeth M. Wiecek Canada 4 698 1.1× 802 2.0× 34 0.6× 62 1.1× 100 2.1× 7 1.1k
L. J. Dordelly United States 8 974 1.5× 334 0.8× 56 1.0× 71 1.3× 110 2.3× 8 1.1k
Kai-Christian Müller Germany 6 986 1.5× 435 1.1× 46 0.8× 101 1.8× 149 3.2× 11 1.1k
Hideki Katsura Japan 16 621 0.9× 194 0.5× 27 0.5× 91 1.7× 50 1.1× 59 806
Can Sevinç Türkiye 12 338 0.5× 103 0.3× 42 0.7× 61 1.1× 56 1.2× 55 534

Countries citing papers authored by Piotr Boros

Since Specialization
Citations

This map shows the geographic impact of Piotr Boros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Boros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Boros more than expected).

Fields of papers citing papers by Piotr Boros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Boros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Boros. The network helps show where Piotr Boros may publish in the future.

Co-authorship network of co-authors of Piotr Boros

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Boros. A scholar is included among the top collaborators of Piotr Boros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Boros. Piotr Boros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kowalska, Justyna, Agata Skrzat‐Klapaczyńska, Agnieszka Bednarska, et al.. (2023). Hospital Admission Factors Independently Affecting the Risk of Mortality of COVID-19 Patients. Journal of Clinical Medicine. 12(19). 6264–6264. 2 indexed citations
3.
4.
Martusewicz-Boros, Magdalena, et al.. (2023). Myocarditis after COVID-19 pneumonia: incidence and risk factors. Polskie Archiwum Medycyny Wewnętrznej. 133(6).
5.
Boros, Piotr & Magdalena Martusewicz-Boros. (2020). New Spirometry? The 2019 Update of the Test Standardization. Advances in respiratory medicine. 88(2). 95–98. 1 indexed citations
6.
Boros, Piotr, Magdalena Martusewicz-Boros, & S Wesółowski. (2018). Gender and smoking – does it matter for lung function in sarcoidosis? An analysis of large cohort (n=1260) Caucasian patients.. PA3000–PA3000. 2 indexed citations
7.
Martusewicz-Boros, Magdalena, Piotr Boros, Elżbieta Wiatr, Justyna Fijołek, & Kazimierz Roszkowski‐Śliż. (2017). Systemic treatment for sarcoidosis was needed for 16% of 1810 Caucasian patients. The Clinical Respiratory Journal. 12(4). 1367–1371. 7 indexed citations
8.
Altraja, Alan, А. S. Belevskiy, Piotr Boros, et al.. (2017). Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of COPD. Volume 13. 45–56. 13 indexed citations
9.
Martusewicz-Boros, Magdalena, et al.. (2016). Prevalence of cardiac sarcoidosis in white population. Medicine. 95(32). e4518–e4518. 32 indexed citations
10.
Mróz, Robert, Paweł Lisowski, Agnieszka Tycińska, et al.. (2015). Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study.. PubMed. 66(1). 111–28. 45 indexed citations
11.
Nowicka, Urszula, Elżbieta Wiatr, Elżbieta Radzikowska, et al.. (2015). Pulmonary Function Abnormalities in Regard to Age at the Time of Diagnosis of Hypersensitivity Pneumonitis. Advances in experimental medicine and biology. 861. 75–84. 5 indexed citations
12.
Przybyłowski, Tadeusz, Waldemar Tomalak, Zenon Siergiejko, et al.. (2015). Polish Respiratory Society Guidelines for the Methodology and Interpretation of the 6 Minute Walk Test (6MWT). Advances in respiratory medicine. 83(4). 283–297. 39 indexed citations
13.
Martusewicz-Boros, Magdalena, Piotr Boros, Elżbieta Wiatr, & Kazimierz Roszkowski‐Śliż. (2014). How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study. European Respiratory Journal. 44(Suppl 58). P464–P464. 1 indexed citations
14.
Wesółowski, S, et al.. (2014). Chronic Obstructive Pulmonary Disease in Poland: Distribution of Patients According to the New GOLD 2011 Classification. Cross-Sectional Survey. Advances in respiratory medicine. 82(6). 511–517. 7 indexed citations
15.
Sobiecka, Małgorzata, et al.. (2013). Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema. European Respiratory Journal. 42(Suppl 57). P3376–P3376. 1 indexed citations
16.
Quanjer, Philip H., Jeffrey J. Pretto, Danny J. Brazzale, & Piotr Boros. (2013). Grading the severity of airways obstruction: new wine in new bottles. European Respiratory Journal. 43(2). 505–512. 113 indexed citations
17.
Quanjer, Philip H., Daniel J. Weiner, Jeffrey J. Pretto, Danny J. Brazzale, & Piotr Boros. (2013). Measurement of FEF 25–75% and FEF 75% does not contribute to clinical decision making. European Respiratory Journal. 43(4). 1051–1058. 161 indexed citations
18.
Boros, Piotr & Wojciech Lubiński. (2012). Health state and the quality of life in patients with chronic obstructive pulmonary disease in Poland. A study using the EQ‑5D questionnaire. Polskie Archiwum Medycyny Wewnętrznej. 122(3). 73–81. 16 indexed citations
19.
Wesółowski, S & Piotr Boros. (2011). How to diagnose restrictive ventilatory defect by spirometry, and reduce the number of lung volumes measurements?. European Respiratory Journal. 38(Suppl 55). p1210–p1210. 1 indexed citations
20.
Boros, Piotr, et al.. (2004). Value of Spirometry in Detecting Volume Restriction in Interstitial Lung Disease Patients. Respiration. 71(4). 374–379. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by An Lehouck Breakdown of academic impact, for papers by Hugues Morel Breakdown of academic impact, for papers by M. C. Zoia Breakdown of academic impact, for papers by Levent Cem Mutlu Breakdown of academic impact, for papers by A. Cavaillès Breakdown of academic impact, for papers by Elizabeth M. Wiecek Breakdown of academic impact, for papers by L. J. Dordelly Breakdown of academic impact, for papers by Kai-Christian Müller Breakdown of academic impact, for papers by Hideki Katsura Breakdown of academic impact, for papers by Can Sevinç
Rankless by CCL
2026